Monster in the making $DFCO timeline in a

New Post Public Reply Private Reply Replies (0) Message Board
RalphKlotz
230
Monster in the making $DFCO timeline in a nutshell:

-2007/2008 prior company is wiped out during the financial collapse. Company settles with debtors and loses all their assets in the process. $DFCO becomes an empty shell with a very healthy share structure.

-2018 Jan/Feb company files with OTC.com showing first signs of life in over a decade and confirms o/s at 47.3m and float at 38.3m.

Over the next nearly 2 years the company begins hiring talent and incorporating new business subsidiaries, with happenings recently bubbling over thanks to filing an audited 10k for the past 2 years with the SEC (first SEC filing in over 10 years!) and 2 huge acquisitions netting millions of revenue for 2020. This on top of one of their own subsidiaries (Dalrada Precision) having $1.4m in orders set for 2020.

There's too much to list but for the past 2 years the company has been putting together this puzzle, piece by piece. The potential here with this company is staggering when you factor it against it's current market cap. Essentially the market has hardly priced in a single update and when this sort of scenario happens, the reaction is violent when the market quickly tries to recalibrate and correct it's inaccurate valuation. Expect many more updates to steadily hit the pipeline from here on out now that they're SEC current and also look for the company to initiate an IR push to help spread the word.

As a chart guy I don't care how great a story is, it's meaningless if the chart isn't confirming all the hype and promise. Well $DFCO has the strongest chart in the OTC atm. In 2018 the stock broke out to a new 9 year high and since then it's done nothing but hold those gains and consolidate on microscopic volume. Now we have a 2 year base built atop a 9 year base, all setup and ready for the most explosive wave yet. This breakout will see new 11 year highs and I will bet the farm that volume comes in and this goes straight for a moonshot. Not even sure what else I can say, just a matter of when the hype train leaves the station.

Screenshot_2020-02-03-DFCO-0-041500-0-Unnamed.png
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NetEase Miss Opens an Investigation, Not a Verdict

Updated Category News Views 132

A two-dollar earnings gap can make a shareholder base jumpy fast, and NetEase just handed the market a rough set of numbers to chew on. The November 19 notice says NetEase's third-quarter 2026 report missed Wall Street expectations on both earnings and revenue, followed by a sharp decline in the shares. That has prompted SueWallSt, powered by Levi & Korsinsky LLP, to...

Continue Reading
SEIA's Young Advisors Put Succession Plans to the Test

Updated Category News Views 15

A $166 million average book is not a cute training-program statistic. It says SEIA’s advisors aged 30 to 39 are already carrying serious client responsibility, and that matters because the registered investment advisory business is headed into a succession crunch nobody can solve with a glossy recruiting brochure. You Cannot Hand Off Trust Like a Spare Key Clients may...

Continue Reading
TOP-REAL Tests Digital Monitoring in HER2 Cancer Care

Updated Category News Views 116

A cancer treatment can be extraordinarily potent and still get derailed by what happens on an ordinary Tuesday at home. That unglamorous gap between clinic visits is the whole point of TOP-REAL, a phase II academic study presented at ESMO AI & Digital Oncology 2026. Solti and its European partners are testing whether closer digital follow-up can catch trouble early enough...

Continue Reading
Midea’s SC26 Cooling Pitch Targets AI Build Delays

Updated Category News Views 80

Heat is the uninvited partner in every AI build, and Midea is making a sensible argument that nobody gets paid for racks sitting idle while piping crews wrestle with a complicated cooling plant. At SC26 in Chicago, held November 17 through 19, the company made its North American debut for a modular prefabricated AI data-center cooling setup built around a magnetic coolant...

Continue Reading
UTI Faces Fresh Scrutiny After Its Earnings Guidance Miss

Updated Category News Views 113

A Guidance Gap That Cannot Be Shrugged Off A $0.20-per-share hole is a nasty thing to find after management said it could see the road ahead. Universal Technical Institute reported fiscal 2026 diluted earnings per share of $0.60, below the $0.71 to $0.80 range it reaffirmed on May 6. That is at least $0.11 under the low end and roughly 21% below the midpoint. For...

Continue Reading
YPTC’s Florida Office Bets on Nonprofit Finance Needs

Updated Category News Views 36

A Local Flag Planted After Years of Work Florida nonprofits do not need another consultant waving a glossy slide deck around; they need clean books, grant compliance, and somebody who can tell them where the cash is going before the lights start blinking red. That is the practical opening YPTC is chasing with a Jacksonville-based Florida office, its sixteenth office...

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 215

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading
BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 119

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
Simmons Clarifies Texas Loan Exposure, But Risks Remain

Updated Category News Views 14

A $45 million discrepancy is not a rounding error, and Simmons First National has every reason to swat it down hard. The bank says recent reporting overstated financing tied to a Texas multifamily development at $133 million. Its stated total is roughly $88 million, with about $44 million participated to another financial institution. For shareholders in NASDAQ:SFNC, that...

Continue Reading
VIGGO’s Mix1Pro Tests Practical Commercial Cleaning

Updated Category News Views 61

A cleaning robot earns its keep in the ugly corners, not under convention-center lights. VIGGO used the ISSA Show North America gathering in Las Vegas, held November 17–19, 2026, to introduce the Mix1Pro, a compact commercial machine aimed at indoor facilities below 53,800 square feet. That target matters. Smaller, messier sites are where autonomy can look terrific on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Enzyme Inhibitor Market Growth Forecast: US$ 5.9 Billion

Updated Category News Views 125

The Future of the Enzyme Inhibitor Market The enzyme inhibitor market is positioned for significant growth, projected to reach US$ 5.9 billion by 2034, following an estimated rise from US$ 2.8 billion in 2023. This impressive growth is driven by a compound annual growth rate (CAGR) of 7.1% over the next decade. Enzyme inhibitors, particularly angiotensin-converting enzyme...

Continue Reading
Li-Cycle Announces $15 Million Public Offering Insights

Updated Category News Views 213

Li-Cycle Announces $15 Million Underwritten Public Offering Li-Cycle Holdings Corp. (NYSE: LICY), a recognized leader in lithium-ion battery resource recovery, has unveiled details about its recent public offering. This strategically planned offering is projected to raise approximately $15 million for the company, providing essential funding to support its ongoing and...

Continue Reading
Investors Encouraged to Join Edwards Lifesciences Case

Updated Category News Views 117

Investors Encouraged to Join Edwards Lifesciences Case In recent developments, the Rosen Law Firm, a dedicated advocate for investor rights, is reaching out to individuals who purchased securities of Edwards Lifesciences Corporation (NYSE: EW) during a specified time frame. This outreach aims to inform these investors about their rights and potential avenues to seek...

Continue Reading
AtlasNova's $2.3M Funding to Transform Small Business Automation

Updated Category News Views 318

AtlasNova Secures $2.3 Million for Small Business Automation With the latest funding, AtlasNova is dedicated to enhancing the operations of small businesses, helping them leverage efficiencies that typically only larger corporations enjoy. Unlocking Potential Through Intelligent Automation AtlasNova has successfully secured a seed round of $2.3 million, enabling them to...

Continue Reading
Congressman Questions SEC's 'Digital Asset Security' Definition

Updated Category News Views 196

Congressman Ritchie Torres Questions SEC's Use of Terminology Representative Ritchie Torres, a Democratic representative from New York, has recently shared his concerns about the phrase "digital asset security" as used by the U.S. Securities and Exchange Commission (SEC). He’s particularly interested in the legal basis and origins of this term. Congressional Dialogue...

Continue Reading